Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on March 9, 2020. The filing serves as a Regulation FD disclosure regarding upcoming investor communications scheduled between March 10, 2020, and March 31, 2020.
Key Financial Metrics
The filing does not report historical revenue, profit, cash flow, margins, debt, or liquidity figures for a specific reporting period. Instead, it provides forward-looking per-share earnings guidance for the full year 2020:
- Full Year 2020 Net Income Guidance: Greater than $21.44 per share.
- Unfavorable Items: Approximately $0.86 per share included in the net income guidance.
- Adjusted Net Income Guidance: Greater than $22.30 per share (excluding the unfavorable items).
Material Changes
The filing does not disclose material changes to financial results compared to prior periods. It explicitly states that the 2020 guidance does not include adjustment items beyond those reported in the full year 2019 earnings release.
Guidance, Outlook, and Risks
Management intends to reaffirm the 2020 earnings guidance during investor meetings. The document includes extensive forward-looking statements subject to significant risks and uncertainties, including:
- Regulatory and Legal: Changes to the Affordable Care Act (ACA), legal challenges to the ACA, and the outcome of litigation with Cigna Corporation regarding a merger agreement.
- Operational: Healthcare cost trends, provider contracting, enrollment levels, and pharmacy benefit management (PBM) transitions involving CVS Health and Express Scripts.
- External Events: Large-scale medical emergencies, specifically citing public health epidemics including COVID-19.
- Financial: Risks related to substantial indebtedness, potential impairment of intangible assets, and liquidity constraints.
Investor Verification Checklist
- Verify the specific composition of the $0.86 per share in "net unfavorable items" referenced in the 2020 guidance.
- Monitor the status and potential financial impact of the litigation between Anthem and Cigna Corporation.
- Assess the operational impact of the COVID-19 pandemic on healthcare utilization and costs as noted in the risk factors.
- Review the full year 2019 earnings release to understand the baseline for the "adjustment items" excluded from the adjusted net income guidance.